[1]
Monteiro, I., Cordeiro, F., Martins, T. e Medeiros, C. 2025. PE-041 Impact associated with pertuzumab and trastuzumab SC and IV formulations utilization in metastatic HER2- positive breast cancer patients treated in SUS. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA. 9, s. 3 (mar. 2025). DOI:https://doi.org/10.22563/2525-7323.2025.v9.s3.p.58.